WELCOME TO

Specialist Communications for Life Sciences
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.

Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:
PR & Media
- Press releases
- Article writing and placement
- Media interviews
- Messaging
- Copy writing
- Social media
- Media training
- Events
Marketing
- Conference, event and trade show support
- Marketing literature
- Market research
- Campaign development
- Advertising
- Sponsorship
- Product launches
Design & Branding
- Website design and development
- Print collateral development
- Identity and logo creation
- Brand strategy
- Presentation development
- Video production
Investor Relations
- Business plan development
- Presentation development
- PR targeting the life science trade press read by investors

The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
EVENTS
-
OBN BioTrinity 2026
-
PEGS Boston
-
BioBeat 2026
-
SLAS Europe 2026
FairJourney Bio Opens Cryo-EM Structural Biology Facility in San Diego
Antibody discovery expert expands presence in US biotech ecosystem with world-leading atomic-resolution structural biology capabilities SAN DIEGO, USA, 10 April 2026: FairJourney Bio (FJBio), a global antibody discovery contract research [...]
William Blair Analysts Name Carterra a Winner in Life Science Tools for Enabling AI Drug Discovery at Unprecedented Scale
Carterra, with its HT-SPR technology platforms, is listed alongside large public companies as a technology provider to capitalize on the likely growth in wet lab work driven by the increasing [...]
Virica Biotech and FUJIFILM Biosciences Collaborate Under the Canada–Japan Co-Innovation Program to Advance AAV Production Enhancers
Efficient production of Adeno-Associated Virus (AAV) vectors at scale for in vivo gene therapies remains a key bottleneck for broad patient access and sustainable manufacturing costs Virica and FUJIFILM Biosciences [...]




















